Shkreli, who talked to ABC News, declined to name the new price for the medicine, which has been on the market for 60 years. ABC described Shkreli as “the most hated man in America.”
Wednesday, September 23, 2015
ANOTHER ARGUMENT FOR BIG GOVERNMENT AND REGULATIONS
And, in this case "CAPS" on profits for medications (rx) so that
predators can't take undue advantage of the sick and most vulnerable who
are desperately trying to prolong their lives. If profits are capped
then the gouging will either stop or the excess can be taxed 100% and go
back into the healthcare system.
Martin
Shkreli, the controversial pharmaceutical CEO and former hedge fund
manager, announced that he would reduce the price of the drug Daraprim
to “a point that is more affordable.”
Shkreli has been the subject of unrelenting criticism since he
implemented a 5000% increase in the price of the drug — from $13.50 per
pill to $750 — which is used to treat severe infections in AIDS patients
and infants.
Shkreli, who talked to ABC News, declined to name the new price for the medicine, which has been on the market for 60 years. ABC described Shkreli as “the most hated man in America.”
Shkreli, who talked to ABC News, declined to name the new price for the medicine, which has been on the market for 60 years. ABC described Shkreli as “the most hated man in America.”
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment